Get the latest Science News and Discoveries

Cybin Reports Positive Topline Data from Phase 2 Study of CYB003 in Major Depressive Disorder with 79% of Patients in Remission after Two 12mg Doses

None

Related news:

Farm-to-school food program a net positive, study finds

Study gives grandmother gecko a place of honor -- and a new name

Novel study finds aspirin-free regimen benefits patients with LVAD